|
Assessing the Increased Variability in Individual Lesion Kinetics During Immunotherapy: Does It Exist, and Does It Matter?
Marion Kerioui
,
Julie Bertrand
,
Solène Desmée
,
Christophe Le Tourneau
,
François Mercier
et al.
Article dans une revue
hal-04636729
v1
|
|
Nonlinear multilevel joint model for individual lesion kinetics and survival to characterize intra-individual heterogeneity in patients with advanced cancer
Marion Kerioui
,
Maxime Beaulieu
,
Solène Desmée
,
Julie Bertrand
,
François Mercier
et al.
Article dans une revue
hal-03695061
v2
|
|
A bayesian version of Galton–Watson for population growth and its use in the management of small population
Bertrand Cloez
,
Tanguy Daufresne
,
Marion Kerioui
,
Bénédicte Fontez
Article dans une revue
hal-04886079
v1
|
|
Modelling the association between biomarkers and clinical outcome: An introduction to nonlinear joint models
Marion Kerioui
,
Julie Bertrand
,
René Bruno
,
François Mercier
,
Jérémie Guedj
et al.
Article dans une revue
hal-04636787
v1
|
|
Longitudinal analysis of organ-specific tumor lesion sizes in metastatic colorectal cancer patients receiving first line standard chemotherapy in combination with anti-angiogenic treatment
Francois Mercier
,
Marion Kerioui
,
Solène Desmée
,
Jeremie Guedj
,
Oliver Krieter
et al.
Article dans une revue
hal-03184393
v1
|
|
Bayesian inference using Hamiltonian Monte‐Carlo algorithm for nonlinear joint modeling in the context of cancer immunotherapy
Marion Kerioui
,
Francois Mercier
,
Julie Bertrand
,
Coralie Tardivon
,
René Bruno
et al.
Article dans une revue
hal-03107209
v1
|
|
Association between tumor size kinetics and survival in urothelial carcinoma patients treated with atezolizumab: implication for patient's follow‐up
Coralie Tardivon
,
Solène Desmée
,
Marion Kerioui
,
René Bruno
,
Benjamin Wu
et al.
Article dans une revue
inserm-02103513
v1
|